Aarti Industries Ltd
Incorporated in 1984, Aarti Industries Ltd manufactures and deals in Speciality Chemicals and Pharmaceuticals[1]
- Market Cap ₹ 20,567 Cr.
- Current Price ₹ 567
- High / Low ₹ 678 / 438
- Stock P/E 46.2
- Book Value ₹ 139
- Dividend Yield 0.44 %
- ROCE 10.4 %
- ROE 11.6 %
- Face Value ₹ 5.00
Pros
Cons
- Tax rate seems low
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -3.98%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,667 | 2,086 | 2,619 | 2,853 | 2,934 | 3,050 | 3,699 | 4,025 | 3,994 | 4,317 | 6,040 | 6,565 | 6,128 | |
1,422 | 1,729 | 2,223 | 2,396 | 2,404 | 2,442 | 3,043 | 3,108 | 3,065 | 3,382 | 4,329 | 5,477 | 5,155 | |
Operating Profit | 245 | 356 | 396 | 456 | 530 | 608 | 657 | 917 | 930 | 935 | 1,711 | 1,088 | 973 |
OPM % | 15% | 17% | 15% | 16% | 18% | 20% | 18% | 23% | 23% | 22% | 28% | 17% | 16% |
3 | 4 | 10 | 5 | 10 | 3 | 2 | 5 | 11 | 2 | 1 | 0 | 0 | |
Interest | 72 | 95 | 118 | 137 | 116 | 117 | 131 | 179 | 122 | 86 | 102 | 166 | 176 |
Depreciation | 54 | 82 | 87 | 79 | 93 | 115 | 136 | 151 | 173 | 218 | 244 | 310 | 348 |
Profit before tax | 122 | 184 | 201 | 246 | 331 | 379 | 392 | 591 | 646 | 632 | 1,366 | 613 | 449 |
Tax % | 29% | 29% | 26% | 24% | 24% | 19% | 19% | 19% | 19% | 19% | 13% | 11% | |
87 | 131 | 149 | 188 | 252 | 307 | 316 | 481 | 523 | 514 | 1,182 | 546 | 445 | |
EPS in Rs | 2.76 | 4.15 | 4.20 | 5.30 | 7.58 | 9.34 | 9.73 | 13.88 | 15.02 | 14.74 | 32.61 | 15.06 | 12.28 |
Dividend Payout % | 32% | 24% | 27% | 26% | 28% | 3% | 3% | 20% | 12% | 10% | 11% | 17% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 12% |
3 Years: | 18% |
TTM: | -13% |
Compounded Profit Growth | |
---|---|
10 Years: | 15% |
5 Years: | 12% |
3 Years: | 2% |
TTM: | -62% |
Stock Price CAGR | |
---|---|
10 Years: | 40% |
5 Years: | 12% |
3 Years: | 1% |
1 Year: | -17% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 20% |
3 Years: | 19% |
Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 40 | 40 | 44 | 44 | 42 | 41 | 41 | 43 | 87 | 87 | 181 | 181 | 181 |
Reserves | 473 | 637 | 734 | 864 | 1,052 | 1,269 | 1,475 | 2,517 | 2,815 | 3,325 | 4,320 | 4,740 | 4,850 |
625 | 846 | 1,037 | 1,201 | 1,275 | 1,545 | 2,047 | 2,366 | 2,073 | 2,851 | 2,581 | 2,907 | 3,205 | |
431 | 550 | 749 | 710 | 467 | 485 | 620 | 702 | 1,115 | 1,251 | 748 | 762 | 1,035 | |
Total Liabilities | 1,568 | 2,073 | 2,565 | 2,819 | 2,836 | 3,341 | 4,182 | 5,628 | 6,089 | 7,514 | 7,830 | 8,590 | 9,271 |
433 | 664 | 793 | 936 | 1,170 | 1,567 | 1,844 | 1,979 | 2,302 | 3,511 | 3,635 | 4,824 | 5,246 | |
CWIP | 54 | 62 | 113 | 188 | 307 | 267 | 431 | 795 | 1,418 | 1,298 | 1,303 | 1,096 | 1,057 |
Investments | 21 | 19 | 32 | 63 | 56 | 62 | 56 | 33 | 37 | 36 | 3 | 12 | 19 |
1,060 | 1,328 | 1,627 | 1,632 | 1,304 | 1,446 | 1,850 | 2,820 | 2,333 | 2,669 | 2,889 | 2,658 | 2,949 | |
Total Assets | 1,568 | 2,073 | 2,565 | 2,819 | 2,836 | 3,341 | 4,182 | 5,628 | 6,089 | 7,514 | 7,830 | 8,590 | 9,271 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
119 | 217 | 292 | 357 | 550 | 411 | 312 | 700 | 1,065 | 844 | 507 | 1,272 | |
-131 | -219 | -271 | -323 | -424 | -470 | -574 | -768 | -1,109 | -1,307 | -1,162 | -1,301 | |
12 | 3 | -19 | -20 | -128 | 57 | 264 | 839 | -520 | 635 | 417 | 55 | |
Net Cash Flow | 1 | 1 | 3 | 14 | -2 | -3 | 2 | 771 | -564 | 173 | -239 | 27 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 89 | 75 | 65 | 60 | 65 | 66 | 69 | 73 | 72 | 69 | 68 | 54 |
Inventory Days | 109 | 150 | 146 | 124 | 104 | 124 | 132 | 139 | 167 | 186 | 137 | 115 |
Days Payable | 58 | 70 | 89 | 57 | 66 | 67 | 67 | 53 | 69 | 121 | 53 | 47 |
Cash Conversion Cycle | 140 | 155 | 122 | 126 | 103 | 123 | 135 | 159 | 169 | 135 | 153 | 122 |
Working Capital Days | 124 | 122 | 102 | 94 | 93 | 94 | 104 | 100 | 96 | 65 | 122 | 96 |
ROCE % | 18% | 21% | 19% | 19% | 20% | 19% | 16% | 18% | 15% | 13% | 22% | 10% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 28 Nov
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 28 Nov
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 27 Nov
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 27 Nov
- Announcement Under Regulation 30 - Attendance Of Company Officials In JM Financial India Conference 20 Nov
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
Concalls
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023Transcript PPT REC
-
Mar 2023TranscriptNotesPPT
-
Mar 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Sep 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Sep 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
-
May 2021Transcript PPT
-
Jan 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
May 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jul 2019TranscriptNotesPPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
May 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Nov 2017TranscriptPPT
-
Aug 2017TranscriptPPT
-
Jun 2017Transcript PPT
-
Mar 2017TranscriptPPT
-
Nov 2016TranscriptPPT
-
Aug 2016TranscriptPPT
-
Jun 2016Transcript PPT
-
Apr 2016TranscriptNotesPPT
-
Mar 2016TranscriptNotesPPT
-
Mar 2016TranscriptNotesPPT
-
Feb 2016Transcript PPT
-
Jan 2016TranscriptNotesPPT
Business Overview:[1][2]
Company manufactures speciality chemicals in Benzene based derivatives. Key value chains include Nitro Chloro Benzenes (NCBs), Di-Chloro Benzenes (DCBs), Phenylenediamines (PDAs), Nitro Toluene Value Chain and Equivalent Sulphuric Acid (E.S.A) & downstream.
Company has 21+ manufacturing units, 100+ products, 700+ domestic customers, 400+ export customers in 60+ countries with major presence in the USA, Europe, Japan, etc.